Nasdaq

Beta Bionics, Inc. Announces Integration of iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor

Beta Bionics plans to integrate its iLet Bionic Pancreas with Abbott's upcoming dual glucose-ketone sensor for enhanced diabetes management. Beta Bionics, Inc. has announced plans to integrate its ...
Yahoo

FDA warns Beta Bionics on unreported complaints, insulin pump changes

Add Yahoo as a preferred source to see more of our stories on Google. Beta Bionics said it plans to integrate its ILet Bionic Pancreas automated insulin delivery system with a glucose-ketone sensor ...
Hosted on MSN

Beta Bionics’ iLet Experience Study: A Game-Changer in Diabetes Management?

Beta Bionics, Inc. ((BBNX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Seeking Alpha

Beta Bionics: It Has Been An Interesting Year

I have been actively covering shares of Beta Bionics, Inc. (BBNX) since the IPO early this year, with my last take in September concluding that the company was guiding conservatively after all. Its ...
Seeking Alpha

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (BBNX), a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its ...